From Fiction to Reality

Jordan Shapiro
Genaerrative
Published in
2 min readMay 28, 2017

An Interview with Jamie Metzl

Find our interview with Jamie Metzl on SoundCloud

Jamie Metzl is a Senior Fellow of the Atlantic Council, novelist, blogger, syndicated columnist, media commentator, and expert in Asian affairs and biotechnology policy. In addition to his work at the Atlantic Council, he is the author of two science fiction novels. Genesis Code is a murder mystery set in 2023 America that focuses on human genetic enhancement and rising competition between the US and China. It sequel, Eternal Sonata, envisions a near future in which life extension is achievable through modern genetics. These novels masterfully blend Metzl’s knowledge of science, policy, and international affairs.

8Image Source: VialDaily

Metzl previously served as Executive Vice President of the Asia Society, Deputy Staff Director of the U.S. Senate Foreign Relations Committee, Senior Coordinator for International Public Information at the U.S. State Department, Director for Multilateral Affairs on the National Security Council, and as a Human Rights Officer for the United Nations in Cambodia. A member of the Council on Foreign Relations and former White House Fellow and Aspen Institute Crown Fellow, Jamie holds a Ph.D. in Asian history from Oxford, a JD from Harvard Law School, and is a magna cum laude, Phi Beta Kappa graduate of Brown University. He has completed thirteen Ironman triathlons, twenty-nine marathons, and twelve ultramarathons.

Jamie Metzl’s full bio is available at his website.

Genaerrative spoke with Metzl to learn more about the roles of international policy, implementation, and science fiction in the current discussion of human gene editing.

Enjoyed this interview? Click the heart to recommend this post, listen to our first podcast with Professor Sheila Jasanoff and follow Genaerrative for more!

--

--

Jordan Shapiro
Genaerrative

VC at NEA, Schwarzman Scholar (Tsinghua University) ‘17, Proud Stanford grad (BS ’15, MS ‘16), Mayfield Fellow, biotech futurist and theater enthusiast.